GeneNews technology able to predict risk of liver cancer for patients with chronic hepatitis

A poster entitled “Biomarkers to predict risk of subsequent hepatocellular cancer in patients with chronic hepatitis,” describing the initial phase of analysis of a 1,600-cohort study using GeneNews’ (TSX:GEN) Sentinel Principle, was presented at the 9th Liver Update 2011 conference in Malaysia. The poster reports on the application of the Sentinel Principle platform technology to [...]

JAMA lymph node study heightens visibility of Neoprobe

  A groundbreaking lymph node study published in The Journal of the American Medical Association last month has turned the spotlight on Neoprobe (AMEX:NEOP) and its lymphatic tissue tracing agent, Lymphoseek. The study described how a routine procedure for the treatment of early breast cancer – the surgical removal of cancerous lymph nodes from the [...]

GeneNews gets Malaysian seed grant

GeneNews (TSX:GEN) has received approval of a seed capital grant of about $625,000 from the Malaysian Biotechnology Corp. to support the commercial launch of its ColonSentry, the world’s first blood-based test to determine a person’s current risk for colorectal cancer, in Malaysia. “Driving the global commercialization and clinical adoption of the ColonSentry test as an [...]

GeneNews partner readying ColonSentry submission

Enzo Biochem’s (NYSE:ENZ) clinical labs division has completed validation testing of the GeneNews (TSX:GEN) ColonSentry pre-screening test for colorectal cancer and is in the final stages of submitting the data package to New York State regulatory authorities, according to a new report by Rodman & Renshaw. Analyst Reni Benjamin writes that the validation “demonstrated consistency [...]

Study backs ColonSentry effectiveness

GeneNews (TSX: GEN) says that a poster describing a 786-patient study entitled “Blood RNA Biomarker Detects Both Left- and Right-sided Colorectal Neoplasms” has been accepted for presentation at the Next Generation Dx Summit in Washington, DC this week. The poster details the application of a seven-gene biomarker panel, which forms the basis of the company’s [...]

« Previous Page